References
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013.
- Kogan MD, Blumberg SJ, Schieve LA. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics. 2009;124:1395–1403.
- Baird G, Simonoff E, Pickles A, et al. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet. 2006;368:210–215.
- Autism, Developmental Disabilities Monitoring Network Surveillance Year Principal I, Centers for Disease C, et al. Prevalence of autism spectrum disorders: autism and developmental disabilities monitoring network, United States, 2006. MMWR Surveill Summ. 2009;58:1–20.
- Autism spectrum disorder. Nurs Stand. 2015;29:19.
- Vijayakumar NT, Judy MV. Autism spectrum disorders: integration of the genome, transcriptome and the environment. J Neurol Sci. 2016;364:167–176.
- Homberg JR, Kyzar EJ, Scattoni ML, et al. Genetic and environmental modulation of neurodevelopmental disorders: translational insights from labs to beds. Brain Res Bull. 2016;125:79–91.
- Modabbernia A, Velthorst E, Reichenberg A. Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses. Mol Autism. 2017;8:13.
- Nardone S, Elliott E. The interaction between the immune system and epigenetics in the etiology of autism spectrum disorders. Front Neurosci. 2016;10:329.
- Ishihara K, Hirano T. BST-1/CD157 regulates the humoral immune responses in vivo. Chem Immunol. 2000;75:235–255.
- Quarona V, Zaccarello G, Chillemi A, et al. CD38 and CD157: a long journey from activation markers to multifunctional molecules. Cytometry B Clin Cytom. 2013;84:207–217.
- Choubey D. DNA-responsive inflammasomes and their regulators in autoimmunity. Clin Immunol. 2012;142:223–231.
- Man SM, Karki R, Kanneganti TD. AIM2 inflammasome in infection, cancer, and autoimmunity: role in DNA sensing, inflammation, and innate immunity. Eur J Immunol. 2016;46:269–280.
- Choubey D, Panchanathan R. Absent in Melanoma 2 proteins in SLE. Clin Immunol. 2017;176:42–48.
- Pereira RM, Martinez GJ, Engel I, et al. JARID2 is induced by TCR signalling and controls iNKT cell maturation. Nat Commun. 2014;5:4540.
- Kitajima K, Kojima M, Nakajima K, et al. Definitive but not primitive hematopoiesis is impaired in jumonji mutant mice. Blood. 1999;93:87–95.
- Landeira D, Bagci H, Malinowski AR, et al. JARID2 coordinates nanog expression and PCP/Wnt signaling required for efficient ESC differentiation and early embryo development. Cell Rep. 2015;12:573–586.
- Berge-Lefranc JL, Jay P, Massacrier A, et al. Characterization of the human jumonji gene. Hum Mol Genet. 1996;5:1637–1641.
- Higashida H, Liang M, Yoshihara T, et al. An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator. BMC Neurosci. 2017;18:35.
- Saresella M, Piancone F, Marventano I, et al. Multiple inflammasome complexes are activated in autistic spectrum disorders. Brain Behav Immun. 2016;57:125–133.
- Di Benedetto D, Di Vita G, Romano C, et al. 6p22.3 deletion: report of a patient with autism, severe intellectual disability and electroencephalographic anomalies. Mol Cytogenet. 2013;6:4.
- Borglum AD, Kirov G, Craddock N, et al. Possible parent-of-origin effect of Dopa decarboxylase in susceptibility to bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet. 2003; 117B:18–22.
- Li J, Meltzer HY. A genetic locus in 7p12.2 associated with treatment resistant schizophrenia. Schizophr Res. 2014;159:333–339.
- Ribases M, Ramos-Quiroga JA, Hervas A, et al. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol Psychiatry. 2009;14:71–85.
- Chaste P, Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci. 2012;14:281–292.
- Yokoyama S, Al Mahmuda N, Munesue T, et al. Association study between the CD157/BST1 gene and autism spectrum disorders in a Japanese population. Brain Sci. 2015;5:188–200.
- Liu X, Shimada T, Otowa T, et al. Genome-wide association study of autism spectrum disorder in the East Asian populations. Autism Res. 2015;9:340–349.
- Ramos PS, Sajuthi S, Langefeld CD, et al. Immune function genes CD99L2, JARID2 and TPO show association with autism spectrum disorder. Mol Autism. 2012;3:4.
- Yu H, Liu J, Yang A, et al. Lack of association between polymorphisms in Dopa decarboxylase and dopamine receptor-1 genes with childhood autism in Chinese Han population. J Child Neurol. 2016;31:560–564.
- Liu J, Mo W, Zhang Z, et al. Single Nucleotide Polymorphisms in SLC19A1 and SLC25A9 are associated with childhood autism spectrum disorder in the Chinese Han population. J Mol Neurosci. 2017;62:262–267.
- Schopler E, Reichler RJ, DeVellis RF, et al. Toward objective classification of childhood autism: childhood autism rating scale (CARS). J Autism Dev Disord. 1980;10:91–103.
- Yong Y, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97–98.
- Ceroni F, Sagar A, Simpson NH, et al. A deletion involving CD38 and BST1 results in a fusion transcript in a patient with autism and asthma. Autism Res. 2014;7:254–263.
- Lopatina O, Yoshihara T, Nishimura T, et al. Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease. Front Behav Neurosci. 2014;8:133.
- Celestino-Soper PB, Skinner C, Schroer R, et al. Deletions in chromosome 6p22.3-p24.3, including ATXN1, are associated with developmental delay and autism spectrum disorders. Mol Cytogenet. 2012;5:17.
- Baroy T, Misceo D, Stromme P, et al. Haploinsufficiency of two histone modifier genes on 6p22.3, ATXN1 and JARID2, is associated with intellectual disability. Orphanet J Rare Dis. 2013;8:3.